| Pharmaceutical Information |
| Drug Name |
Ergotamine tartrate |
| Drug ID |
BADD_D00797 |
| Description |
A vasoconstrictor found in ergot of Central Europe. It is an alpha-1 selective adrenergic agonist and is commonly used in the treatment of migraine disorders. |
| Indications and Usage |
For use as therapy to abort or prevent vascular headache, e.g., migraine, migraine variants, or so called "histaminic cephalalgia". |
| Marketing Status |
approved |
| ATC Code |
N02CA02 |
| DrugBank ID |
DB00696
|
| KEGG ID |
D00679
|
| MeSH ID |
D004878
|
| PubChem ID |
9787
|
| TTD Drug ID |
D01TSI
|
| NDC Product Code |
38779-0219; 47848-001; 55486-1581; 70720-120 |
| UNII |
MRU5XH3B48
|
| Synonyms |
Ergotamine | Ergomar | Ergostat | Ergotamine Tartrate | Tartrate, Ergotamine | Ergotamine Tartrate (2:1) | Ergotaminine | Ergo-Kranit | Ergo Kranit | Lingraine | Cornutamine | Ergo Sanol | Ergodryl Mono | Mono, Ergodryl | Gynergen |
|
| Chemical Information |
| Molecular Formula |
C70H76N10O16 |
| CAS Registry Number |
379-79-3 |
| SMILES |
CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C
6=C5)C.CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC
(=C78)C6=C5)C.C(C(C(=O)O)O)(C(=O)O)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
